Glaxo and Johnson & Johnson top a new measure of how drugmakers do against antibiotic-resistant bacteria, which are becoming a global emergency.
Published: January 23, 2018 at 01:00AM
from NYT Health https://ift.tt/2Dxuy4Y
Glaxo and Johnson & Johnson top a new measure of how drugmakers do against antibiotic-resistant bacteria, which are becoming a global emergency.
Published: January 23, 2018 at 01:00AM
from NYT Health https://ift.tt/2Dxuy4Y